PRECIGEN, INC. — Director's Dealing 2021

Jun 22, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2021-06-10

Reporting Person: Lambert James Vincent (Ex. Dir. Fin., PGEN Ther. Inc.)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12356	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase Common Stock (Right to Buy)	$22.56	2027-06-16	Common Stock (10000)		Direct
Option to Purchase Common Stock (Right to Buy)	$8.17	2031-04-21	Common Stock (10000)		Direct
Restricted Stock Units	$		Common Stock (2170)		Direct

Footnotes

F1: The stock options are fully vested.

F2: The stock options vest in equal installments on each of April 21, 2022, April 21, 2023, April 21, 2024 and April 21, 2025.

F3: The restricted stock units ("RSUs") vest in full on January 2, 2022.

F4: Each RSU represents a contingent right to receive one share of Precigen Common Stock.